Citations

Showing 10 of 107969 citations.

Missed Opportunities: A Descriptive Analysis of CAM Discussions and Practices in the Management of Pain in Oncology Patients
Leppin, Aaron L. , James, Katherine M. , Geller, Gail , Tilburt, Jon C.

Mayo Clinic

The Journal of Alternative and Complementary Medicine | May 7, 2014 | Volume: 20 | Issue: 5 | Pages: A111-A111

10.1089/acm.2014.5295.abstract Get It

Integration of A Stress Management and Resiliency Training (SMART) Program in a Nurse Residency Program: A Feasibility Study
Sood, Amit , Morin, Karen H. , Cutshall, Susan, Douglas, Kristin Vickers, Chesak, Sherry S. , Cutshall, Susanne M. , Ridgeway, Jennifer L.

Mayo Clinic

The Journal of Alternative and Complementary Medicine | May 7, 2014 | Volume: 20 | Issue: 5 | Pages: A101-A101

10.1089/acm.2014.5267.abstract Get It

Mind-Body Medicine and Irritable Bowel Syndrome: A Randomized Control Trial Using Stress Reduction and Resiliency Training
Sharma, Varun , Saito, Yuri A. , Amit, Sood, Amit, Sood

Mayo Clinic

The Journal of Alternative and Complementary Medicine | May 7, 2014 | Volume: 20 | Issue: 5 | Pages: A94-A94

10.1089/acm.2014.5248.abstract Get It

Medical Students Familiarity, Experience and Attitudes Towards Complementary and Alternative Medicine
Wahner‐Roedler, Dietlind L. , Loehrer, Laura L., Cha, Stephen , Bauer, Brent A.

Mayo Clinic

The Journal of Alternative and Complementary Medicine | May 7, 2014 | Volume: 20 | Issue: 5 | Pages: A77-A77

10.1089/acm.2014.5202.abstract Get It

Review of comorbidities and risk factors for the development of migraine complications (infarct and chronic migraine)
Dodick, DW

Mayo Clinic

Cephalalgia | May 7, 2014 | Volume: 29 | Issue: 3_suppl | Pages: 7-14

10.1177/03331024090290s303 | PMID 20017749 Get It

A number of comorbid disorders, behavioural traits and associated risk factors in patients with migraine are known to increase the risk of complications such as ischaemic vascular events and chronic migraine, a syndrome that is more disabling and resistant to treatment with acute and preventative medications than episodic migraine. Reduction of cardiovascular risk factors, smoking cessation and use of non-oestrogen-containing oral contraceptives in female patients are beneficial strategies to reduce the risk of ischaemic events in patients with migraine (especially those with aura). Attack frequency, acute medication overuse, obesity and coexisting depression and anxiety disorders are particularly strong but potentially modifiable independent risk factors for progression to chronic migraine. Identifying and managing comorbidities and associated risk factors for complications of migraine are likely to require an integrated disease management strategy involving several disciplines and allied health services. Such a disease-oriented model of care may potentially interrupt the cycle of progression and disability and improve quality of life for patients with migraine.
Iatrogenic Cushing Syndrome Secondary to Ritonavir-Epidural Triamcinolone Interaction: An Illustrative Case and Review
Sadarangani, Sapna P. , Berg, Melody L. , Mauck, William D. , Rizza, Stacey A. , Sadarangani, Sapna , Mauck, William , Rizza, Stacey

Mayo Clinic

Interdisciplinary Perspectives on Infectious Diseases | May 7, 2014 | Volume: 2014 | Issue: No issue available | Pages: 1-7

10.1155/2014/849432 | PMID 24895495 Get It

HIV positive patients on ritonavir-containing antiretroviral therapy (ART) can develop iatrogenic Cushing syndrome (IACS) and adrenal insufficiency as a result of drug-drug interactions with inhaled or intranasal glucocorticoid therapy. Reports related to epidural triamcinolone injections are relatively uncommon but increasingly reported. We describe a 48-year-old woman with immunologically and virologically well-controlled HIV on ritonavir-based ART, who developed headache, dizziness, and candida and herpes simplex virus (HSV) ulcerative esophagitis 7 days after receiving an epidural triamcinolone injection for cervical radicular pain. Iatrogenic Cushing syndrome and relative adrenal insufficiency were suspected and proven. The patient’s ART was changed to a non-HIV protease inhibitor- (PI-) containing program, her symptoms improved, and she did not require hydrocortisone replacement. In this paper, we review the literature on IACS and relative secondary adrenal insufficiency from epidural triamcinolone injections in HIV patients on ritonavir-containing ART regimens. A high index of clinical suspicion is needed for diagnosis. Prevention of drug-drug interactions by taking a thorough medication history for patients on ritonavir-containing ART regimens before prescribing any form of corticosteroid is crucial and effective and sustained interdisciplinary communication in the care of such patients.
Identification of a novel phosphorylation site in adipose triglyceride lipase as a regulator of lipid droplet localization
Xie, Xitao, Langlais, Paul R. , Heckmann, Bradlee L. , Saarinen, Alicia M., Mandarino, Lawrence J. , Liu, Jun , Langlais, Paul, Zhang, Xiaodong , Liu, Jun , Liu, Jun

Mayo Clinic

American Journal of Physiology-Endocrinology and Metabolism | May 7, 2014 | Volume: 306 | Issue: 12 | Pages: E1449-E1459

10.1152/ajpendo.00663.2013 | PMID 24801391 Get It

Adipose triglyceride lipase (ATGL), the rate-limiting enzyme for triacylglycerol (TG) hydrolysis, has long been known to be a phosphoprotein. However, the potential phosphorylation events that are involved in the regulation of ATGL function remain incompletely defined. Here, using a combinatorial proteomics approach, we obtained evidence that at least eight different sites of ATGL can be phosphorylated in adipocytes. Among them, Thr372 resides within the hydrophobic region known to mediate lipid droplet (LD) targeting. Although it had no impact on the TG hydrolase activity, substitution of phosphorylation-mimic Asp for Thr372 eliminated LD localization and LD-degrading capacity of ATGL expressed in HeLa cells. In contrast, mutation of Thr372 to Ala gave a protein that bound LDs and functioned the same as the wild-type protein. In nonstimulated adipocytes, the Asp mutation led to decreased LD association and basal lipolytic activity of ATGL, whereas the Ala mutation produced opposite effects. Moreover, the LD translocation of ATGL upon β-adrenergic stimulation was also compromised by the Asp mutation. In accord with these findings, the Ala mutation promoted and the Asp mutation attenuated the capacity of ATGL to mediate lipolysis in adipocytes under both basal and stimulated conditions. Collectively, these studies identified Thr372 as a novel phosphorylation site that may play a critical role in determining subcellular distribution as well as lipolytic action of ATGL.
Transcriptional atlas of cardiogenesis maps congenital heart disease interactome
Martinez‐Fernandez, Almudena , Hartjes, Katherine A., Kocher, Jean‐Pierre , Olson, Timothy M. , Nelson, Timothy J., Martinez-Fernandez, Almudena, Xing, Li , Terzic, André , Nelson, Timothy J. , Olson, Timothy M

Mayo Clinic

Physiological Genomics | May 7, 2014 | Volume: 46 | Issue: 13 | Pages: 482-495

10.1152/physiolgenomics.00015.2014 | PMID 24803680 Get It

Mammalian heart development is built on highly conserved molecular mechanisms with polygenetic perturbations resulting in a spectrum of congenital heart diseases (CHD). However, knowledge of cardiogenic ontogeny that regulates proper cardiogenesis remains largely based on candidate-gene approaches. Mapping the dynamic transcriptional landscape of cardiogenesis from a genomic perspective is essential to integrate the knowledge of heart development into translational applications that accelerate disease discovery efforts toward mechanistic-based treatment strategies. Herein, we designed a time-course transcriptome analysis to investigate the genome-wide dynamic expression landscape of innate murine cardiogenesis ranging from embryonic stem cells to adult cardiac structures. This comprehensive analysis generated temporal and spatial expression profiles, revealed stage-specific gene functions, and mapped the dynamic transcriptome of cardiogenesis to curated pathways. Reconciling known genetic underpinnings of CHD, we deconstructed a disease-centric dynamic interactome encoded within this cardiogenic atlas to identify stage-specific developmental disturbances clustered on regulation of epithelial-to-mesenchymal transition (EMT), BMP signaling, NF-AT signaling, TGFb-dependent EMT, and Notch signaling. Collectively, this cardiogenic transcriptional landscape defines the time-dependent expression of cardiac ontogeny and prioritizes regulatory networks at the interface between health and disease.
Integration of e-consultations into the outpatient care process at a tertiary medical centre
North, Frederick , Uthke, Lorraine D, Tulledge‐Scheitel, Sidna M.

Mayo Clinic

Journal of Telemedicine and Telecare | May 7, 2014 | Volume: 20 | Issue: 4 | Pages: 221-229

10.1177/1357633x14533886 | PMID 24803274 Get It

An e-consultation is an asynchronous consultation performed by a specialist without a face-to-face patient visit. E-consultations have been available to primary care providers at the Mayo Clinic for several years. We reviewed e-consultations performed by specialists at the Mayo Clinic for the first six months of 2013. We included only “internal” e-consultations, originating from within the Rochester practice. During the study period a total of 3242 e-consultations were completed at the Mayo Clinic. After excluding those relating to patients who did not give research consent, 3008 e-consultations remained. We categorized our internal e-consultations into eight types. The most frequently used types were the first e-consultation processes to be implemented: the primary care to specialist e-consultation and the specialist to specialist e-consultation, accounting for 74% of the total. As these two types of e-consultation became widely used, the staff discovered that the e-consultation process could be adapted to meet specific practice needs and six more e-consultation types emerged. For example, intra-specialty e-consultations and surgical e-consultations accounted for 16% of the total. E-consultations appear to have improved access to specialists, and they are integrated into care processes when timely expert opinions are needed. As e-consultations evolve, it will be important to develop a standard, well-defined terminology to compare outcomes of these processes across practices.
Selection Via Pluripotency-Related Transcriptional Screen Minimizes the Influence of Somatic Origin on iPSC Differentiation Propensity
Hartjes, Katherine A., Martinez‐Fernandez, Almudena , Roemmich, Alexa Joanna, Larsen, Brandon T. , Li, Xing , Terzic, André , Nelson, Timothy J.

Mayo Clinic

Stem Cells | May 6, 2014 | Volume: 32 | Issue: 9 | Pages: 2350-2359

10.1002/stem.1734 | PMID 24802033 Get It

Abstract The value of induced pluripotent stem cells (iPSCs) within regenerative medicine is contingent on predictable and consistent iPSC differentiation. However, residual influence of the somatic origin or reprogramming technique may variegate differentiation propensity and confound comparative genotype/phenotype analyses. The objective of this study was to define quality control measures to select iPSC clones that minimize the influence of somatic origin on differentiation propensity independent of the reprogramming strategy. More than 60 murine iPSC lines were derived from different fibroblast origins (embryonic, cardiac, and tail tip) via lentiviral integration and doxycycline-induced transgene expression. Despite apparent equivalency according to established iPSC histologic and cytomorphologic criteria, clustering of clonal variability in pluripotency-related gene expression identified transcriptional outliers that highlighted cell lines with unpredictable cardiogenic propensity. Following selection according to a standardized gene expression profile calibrated by embryonic stem cells, the influence of somatic origin on iPSC methylation and transcriptional patterns was negated. Furthermore, doxycycline-induced iPSCs consistently demonstrated earlier differentiation than lentiviral-reprogrammed lines using contractile cardiac tissue as a measure of functional differentiation. Moreover, delayed cardiac differentiation was predominately associated with upregulation in pluripotency-related gene expression upon differentiation. Starting from a standardized pool of iPSCs, relative expression levels of two pluripotency genes, Oct4 and Zfp42, statistically correlated with enhanced cardiogenicity independent of somatic origin or reprogramming strategy (R2 = 0.85). These studies demonstrate that predictable iPSC differentiation is independent of somatic origin with standardized gene expression selection criteria, while the residual impact of reprogramming strategy greatly influences predictable output of tissue-specification required for comparative genotype/phenotype analyses. Stem Cells 2014;32:2350–2359